DNA test could predict future brain tumor relapses in kids
Drs. Erin Crotty and Margot Lazow were motivated by their young, resilient patients to spend their careers studying some of the most...
Could knowing genetic ancestry improve rhabdomyosarcoma outcomes?
Unlike some other childhood cancers, the outlook for RMS patients has not improved in recent years: five-year survival rates are less than...
Race Against Rare Leukemia – CCRF donors helped create a treatment where one had never existed before
CCRF donors raced against rare leukemia, and now they're bringing treatments to the finish line and honoring the bravery of two little girls....
Emily Stene, RN, BSN – Guiding Cancer Survivors Through the Medical System
Anyone who has had to navigate the medical system knows it isn’t exactly a breeze. But it’s especially difficult for childhood cancer survi...
Freezing cancer to death: A promising new therapy for rhabdomyosarcoma
When you think of childhood cancer treatments, turning a tumor into an ice ball and melting it is probably not the first therapy that comes...
Could data help us prevent some childhood cancers?
Thanks to donations from supporters like you, the Childhood Cancer & Leukemia International Consortium (CLIC; www.clic.ngo) is ushering in a...
Improving access to cutting-edge cancer care
Growing up as the child of immigrants, Jenny Ruiz, MD, regularly went to the doctor’s office with her grandfather, a kidney transplant...
Developing better therapies for hard-to-treat rhabdomyosarcoma
Amit Sabnis, MD, still remembers one of the first patients he cared for as an oncology fellow. The young man survived rhabdomyosarcoma, a...
A powerful new drug could be osteosarcoma’s match
Alex Huang, MD, PhD has searched unceasingly for readily available drug options that could cure osteosarcoma in its deadliest form, so kids...
Ewing sarcoma research that began with CCRF funding is selected for multimillion dollar grant
Ewing sarcoma researcher Beau Webber, PhD, and epidemiologist Logan Spector, PhD were selected for a multimillion-dollar National Institutes...
Using nanoparticles to fight hard-to-treat brain tumors
Pediatric neurosurgeon Peter Chiarelli, MD, PhD, who leads the Nanoscaled Neuro-technology Research Group at Children’s Hospital Los Angeles,...
A vaccine for hard-to-treat osteosarcoma
Dr. Kleinerman is a professor of Pediatrics and Cancer Biology at University of Texas M.D. Anderson Cancer Center. With support from an...
CCRF Awards Eight New Emerging Scientists
Through a selective granting process, Children's Cancer Research Fund (CCRF) recently awarded these eight promising scientists the Emerging...
Expanding research for kids with myeloid malignancies
Dr. Jessica Pollard is determined to solve a puzzle: myelodysplastic syndrome (MDS), a bone marrow disorder that affects the development of...
The Top Five Research Projects We’re Watching This Childhood Cancer Awareness Month
Childhood cancer is a big problem to solve – there are more than 12 types and more than 100 different subtypes of childhood cancer. This...
Two ways to take aim at childhood brain tumors
Dr. Okay Saydam, MSc, PhD, a researcher at the University of Minnesota, has been working on ways to beat brain tumors for the past 15 years....
Targeting high-risk neuroblastoma in kids
When targeted therapies first began to emerge on the adult oncology scene, Anthony Faber, PhD was ecstatic about the possibilities. But after...
CCRF’s new award aims to close gaps in childhood cancer research and outcomes
Through a new partnership with the Diversity and Health Disparities Committee of the Children’s Oncology Group (COG), Children’s Cancer...